Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print September 13, 2007, doi:10.1212/01.wnl.0000275523.95103.36)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Video
Right arrow All Versions of this Article:
01.wnl.0000275523.95103.36v1
69/22/2045    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wuttke, T. V.
Right arrow Articles by Lerche, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wuttke, T. V.
Right arrow Articles by Lerche, H.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow EMG
Right arrow Neonatal seizures
Right arrow Ion channel gene defects
NEUROLOGY 2007;69:2045-2053
© 2007 American Academy of Neurology

Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations

T. V. Wuttke, MD, K. Jurkat-Rott, MD, W. Paulus, MD, M. Garncarek, MD, F. Lehmann-Horn, MD and H. Lerche, MD

From Institut für Angewandte Physiologie (T.V.W., K.J.-R., M.G., F.L.-H., H.L.) and Neurologische Klinik (T.V.W., M.G., H.L.), Universität Ulm; and Abteilung Klinische Neurophysiologie (W.P.), Universität Göttingen, Germany.

Address correspondence and reprint requests to Prof. Dr. med. Holger Lerche, Neurologische Klinik und Institut für Angewandte Physiologie, Universität Ulm, Zentrum Klinische Forschung, Helmholtzstr. 8/1, 89081 Ulm, Germany holger.lerche{at}uni-ulm.de

Background: Peripheral nerve hyperexcitability (PNH) is characterized by muscle overactivity due to spontaneous discharges of lower motor neurons usually associated with antibodies against voltage-gated potassium channels. PNH may also occur in combination with episodic ataxia or epilepsy caused by mutations in KV1.1 or KV7.2 channels. Only one PNH-associated mutation has been described so far in KV7.2 (R207W), in a family with both PNH and neonatal seizures.

Methods: PNH was characterized by video and electromyography. The KCNQ2 gene was sequenced and KV7.2 channels were functionally characterized using two-microelectrode voltage-clamping in Xenopus oocytes.

Results: In a patient with PNH without other neurologic symptoms, we identified a novel KCNQ2 mutation predicting loss of a charged residue within the voltage sensor of KV7.2 (R207Q). Functional analysis of both PNH-associated mutants revealed large depolarizing shifts of the conductance-voltage relationships and marked slowing of the activation time course compared to wild type (WT) channels, less pronounced for R207Q than R207W. Co-expression of both mutant with WT channels revealed a dominant negative effect reducing the relative current amplitudes after short depolarizations by >70%. The anticonvulsant retigabine, an activator of neuronal KV7 channels, reversed the depolarizing shift.

Conclusions: Mutations in KCNQ2 can cause idiopathic PNH alone and should be considered in sporadic cases. Both KV7.2 mutants produce PNH by changing voltage-dependent activation with a dominant negative effect on the WT channel. This distinguishes them from all hitherto examined Kv7.2 or KV7.3 mutations which cause neonatal seizures by haploinsufficiency. Retigabine may be beneficial in treating PNH.

Abbreviations: BFNC = benign familial neonatal convulsions; EA-1 = episodic ataxia with myokymia; EMG = electromyography; PNH = peripheral nerve hyperexcitability; VGKC = voltage-gated potassium channels; WT = wild type.


Formula

Formula

Supplemental data at www.neurology.org

See also page 2036

e-Pub ahead of print on September 12, 2007, at www.neurology.org.

Supported by grants from the Bundesministerium für Bildung und Forschung (BMBF/NGFN2: 01GS0478), The European Union (EPICURE: LSH-CT-2006-037315) FP 6-Thematic priority LIFESCIHEALTH, the Landesforschungsschwerpunkt Baden-Württemberg (1423/74), the Fritz-Thyssen-Stiftung, and the Deutsche Forschungsgemeinschaft (DFG: Le1030/9-1) (to HL). TVW was supported by a fellowship from the University of Ulm. HL is a Heisenberg fellow of the DFG.

Disclosure: The authors report no conflicts of interest.

Received March 15, 2007. Accepted in final form May 21, 2007.




This article has been cited by other articles:


Home page
Biophys. JHome page
F. Miceli, M. V. Soldovieri, C. C. Hernandez, M. S. Shapiro, L. Annunziato, and M. Taglialatela
Gating Consequences of Charge Neutralization of Arginine Residues in the S4 Segment of Kv7.2, an Epilepsy-Linked K+ Channel Subunit
Biophys. J., September 1, 2008; 95(5): 2254 - 2264.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Maljevic, T. V. Wuttke, and H. Lerche
Nervous system KV7 disorders: breakdown of a subthreshold brake
J. Physiol., April 1, 2008; 586(7): 1791 - 1801.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. V. Wuttke, J. Penzien, M. Fauler, G. Seebohm, F. Lehmann-Horn, H. Lerche, and K. Jurkat-Rott
Neutralization of a negative charge in the S1 S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy
J. Physiol., January 15, 2008; 586(2): 545 - 555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.